🟢 Vera Therapeutics is trading 6.66% up in pre-market — no clear company-specific catalyst

Vera Therapeutics is trading at $33.00, up 6.66% in pre-market, with no clear, new company-specific catalyst identified for October 29.

• Shares had also risen on October 27 and 28, following positive ORIGIN 3 results for TRUTAKNA reported October 22; those results are prior context, not a confirmed explanation for this move.
• Market futures were lower, but that does not establish a broad-market explanation for the gain.
• Pre-market volume or activity level was not reliably available.